Search - tctmd.com

Displaying 21 - 40 of 145

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Short and long term prognostic value of new onset LBBB post Transcatheter Aortic Valve Replacement

Presenter: George M. Yousef

September 25, 2018

Presentation TCT 2018

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Wojtek Wojakowski, Mirvat Alasnag, Ori Ben-Yehuda, Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Mohamed Ahmed Sobhy, Pedro de Araujo Goncalves

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

Presenter: Horst Sievert, Brian K. Whisenant, Marco Barbanti

September 23, 2018

Presentation TCT 2018

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Presenter: Horst Sievert, Brian K. Whisenant, Jeffrey J. Popma

September 23, 2018

Presentation TCT 2018

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Presenter: Valentin Fuster, Howard C. Herrmann

September 23, 2018

Presentation TCT 2018

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Presenter: Alfredo Trento

September 22, 2018

Presentation TCT 2018

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Presenter: Michael J. Mack

September 22, 2018

Presentation TCT 2018

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Presenter: Patrick T. O'Gara

September 22, 2018

Presentation TCT 2018

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Presenter: Martin B. Leon

September 22, 2018

Presentation TCT 2018

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Presenter: Joseph E. Bavaria

September 22, 2018

Presentation TCT 2018

Opinion Concerns of TAVR Access for Underserved Populations

Presenter: Aaron Horne, Jr.

September 22, 2018

Presentation TCT 2018

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Presenter: Mark J. Russo

September 22, 2018

Presentation TCT 2018

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

Presenter: Carl L. Tommaso

September 22, 2018

Presentation TCT 2018

TCT-7: Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement

Presenter: Steven R. Bailey, Patrick W. Serruys, Jennifer Rymer

September 22, 2018

Presentation TCT 2018

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

Presenter: Steven R. Bailey, Patrick W. Serruys, Julia Seeger

September 22, 2018

Presentation TCT 2018

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Presenter: Alain G. Cribier, Helene Eltchaninoff, Herbert Kroon

September 21, 2018

Presentation TCT 2018

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

Presenter: Alex Chebl, Alexandra J. Lansky, Liang Tang

September 21, 2018

Presentation TCT 2018

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Presenter: Alex Chebl, Alexandra J. Lansky, Chetan Huded

September 21, 2018

Advertisement

Short and long term prognostic value of new onset LBBB post Transcatheter Aortic Valve Replacement

Case 1 (A): Left Main Stem (LMS Percutaneous Coronary Intervention (PCI) With High Speed Rotational Atherectomy (HSRA) Prior To Transcatheter Aortic Valve Replacement (TAVR)

High Mortality but Durable Results With Valve-in-Valve TAVR

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Opinion Patient Preferences and Shared Decision-Making Requires Open Access to Both TAVR and SAVR

Counterpoint SAVR Is the Gold Standard and Deserves Priority Treatment!

Point Parity Should Include Valve Assessments, Regulatory Standards, and Equal Patient Access

Opinion Tiered Systems of Care Are Preferred to Optimize Patient Care In Valvular Heart Disease

Counterpoint Volume Thresholds Distort Clinical Practice, Quality Metrics are the Priority and Have a Greater Impact on Outcomes

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Opinion Concerns of TAVR Access for Underserved Populations

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

TCT-7: Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content